Pearce Andrew C, Wonerow Peter, Marshall Stuart J, Frampton Jon, Gartner T Kent, Watson Steve P
Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UK.
Biochem J. 2004 Feb 15;378(Pt 1):193-9. doi: 10.1042/BJ20031298.
The seven-amino-acid peptide LSARLAF has been reported to activate platelets via the integrin GPIIb-IIIa (glycoprotein IIb-IIIa). Activation by LSARLAF is reinforced by release of ADP and thromboxanes, but the initiating event in the signalling cascade is not known. In the present study, we demonstrate that LSARLAF stimulates Src kinase-dependent tyrosine phosphorylation of many of the proteins in the GPIIb-IIIa cascade, including the tyrosine kinase Syk, the adapter SLP-76 (SH2-containing leucocyte phosphoprotein of 76 kDa) and PLCgamma2 (phospholipase Cgamma2). A critical role for PLCgamma2 in signalling by LSARLAF was demonstrated by abolition of aggregation in PLCgamma2-/- murine platelets to low concentrations of the peptide, although a partial recovery was seen with higher concentrations. In sharp contrast with the GPIIb-IIIa-regulated signalling cascade, aggregation was inhibited in murine platelets deficient in the adapter LAT (linker for activation of T-cells) and the Fc receptor gamma-chain. Aggregation was also partially inhibited by the cholesterol-lowering reagent, beta-methyl-cyclodextrin, at concentrations that disrupt membrane rafts, but do not interfere with signalling by GPIIb-IIIa. Furthermore, LSARLAF also stimulated tyrosine phosphorylation in GPIIb-deficient murine platelets, confirming that the integrin is not critical for activation of intracellular signalling pathways. LSARLAF also stimulated Ca2+ elevation in RBL-2H3 cells, which lack the platelet glycoproteins GPIIb, GPVI and GPIb. These results demonstrate that LSARLAF activates platelets through a PLCgamma2-dependent pathway that lies downstream of Src kinases and which is partially dependent on the Fc receptor gamma-chain, LAT and lipid rafts. The mechanism of cell activation by LSARLAF remains to be established, although the present results indicate that more than one surface glycoprotein may mediate this response.
据报道,七氨基酸肽LSARLAF可通过整合素GPIIb-IIIa(糖蛋白IIb-IIIa)激活血小板。LSARLAF的激活作用会因ADP和血栓烷的释放而增强,但信号级联反应中的起始事件尚不清楚。在本研究中,我们证明LSARLAF可刺激GPIIb-IIIa信号级联反应中许多蛋白质的Src激酶依赖性酪氨酸磷酸化,包括酪氨酸激酶Syk、衔接蛋白SLP-76(76 kDa含SH2结构域的白细胞磷蛋白)和PLCγ2(磷脂酶Cγ2)。PLCγ2在LSARLAF信号传导中的关键作用通过PLCγ2基因敲除小鼠血小板对低浓度该肽的聚集反应消失得以证明,尽管在较高浓度时可观察到部分恢复。与GPIIb-IIIa调节的信号级联反应形成鲜明对比的是,在缺乏衔接蛋白LAT(T细胞激活连接蛋白)和Fc受体γ链的小鼠血小板中,聚集受到抑制。胆固醇降低试剂β-甲基环糊精在破坏膜筏但不干扰GPIIb-IIIa信号传导的浓度下,也可部分抑制聚集。此外,LSARLAF还可刺激缺乏血小板糖蛋白GPIIb的小鼠血小板中的酪氨酸磷酸化,证实整合素对细胞内信号通路的激活并非至关重要。LSARLAF还可刺激缺乏血小板糖蛋白GPIIb、GPVI和GPIb的RBL-2H3细胞中的Ca2+升高。这些结果表明,LSARLAF通过Src激酶下游的PLCγ2依赖性途径激活血小板,该途径部分依赖于Fc受体γ链、LAT和脂筏。尽管目前的结果表明可能有不止一种表面糖蛋白介导这种反应,但LSARLAF激活细胞的机制仍有待确定。